50850-26-5

Basic information

• Product Name: 1,5-diacetyloctahydro-3,7-dinitro-1,3,5,7-tetrazocine
• Synonyms: 1,5-diacetyloctahydro-3,7-dinitro-1,3,5,7-tetrazocine
• CAS NO: 50850-26-5
• Molecular Formula: C₈H₁₄N₆O₆
• Molecular Weight: 290.23336
• EINECS: 256-799-3
• Mol File: 50850-26-5.mol
• Article Data: 4

Chemical Properties

• Boiling Point: 716.3°Cat760mmHg
• Flash Point: 387°C
• Appearance: /
• Density: 1.55g/cm³
• Vapor Pressure: 2.29E-20mmHg at 25°C
• Refractive Index: 1.61
• CAS DataBase Reference: 1,5-diacetyloctahydro-3,7-dinitro-1,3,5,7-tetrazocine(CAS DataBase Reference)
• NIST Chemistry Reference: 1,5-diacetyloctahydro-3,7-dinitro-1,3,5,7-tetrazocine(50850-26-5)
• EPA Substance Registry System: 1,5-diacetyloctahydro-3,7-dinitro-1,3,5,7-tetrazocine(50850-26-5)

Safety Data

• Hazardous Substances Data: 50850-26-5(Hazardous Substances Data)

Usage

Physical state

Colorless crystalline solid

Chemical stability

High level of chemical stability

Resistance

Resistant to heat, shock, and friction

Detonation velocity

High detonation velocity

Sensitivity to initiation

Low sensitivity to initiation

Applications

Military and industrial applications, including ammunition, propellants, and detonators

Component

Valuable component in the production of insensitive munitions and high-performance explosives

Health and environmental risks

Poses potential risks to human health and the environment

Handling and storage

Must be handled and stored with care to prevent accidental detonation or exposure

InChI:InChI=1/C8H14N6O6/c1-7(15)9-3-11(13(17)18)5-10(8(2)16)6-12(4-9)14(19)20/h3-6H2,1-2H3

Upstream product

• 50850-27-6 1,5‐diacetyl‐3‐nitroso‐7‐nitro‐1,3,5,7‐tetraazacyclooctane 
• 100-97-0 hexamethylenetetramine 
• 949-56-4 3,7-dinitro-1,3,5,7-tetraaza-bicyclo[3.3.1]nonane 
• 75-36-5 acetyl chloride 
• 32516-05-5 3,7-diacetyl-1,3,5,7-tetraaza-bicyclo[3.3.1]nonane 

Downstream Products

• 2691-41-0 octahydro-1,3,5,7-tetranitro-1,3,5,7-tetrazocine 

Relevant articles and documents

Identifying urotropine derivatives as co-donors of formaldehyde and nitric oxide for improving antitumor therapy

A pharmacophore integration strategy was utilized to develop the first co-donor of formaldehyde and nitric oxide (FANO), composed of urotropine derived nitramine/nitrosamine. FANO simultaneously generated formaldehyde and nitric oxide on-demand, resulting in synergistic anticancer effects. Importantly, liposomal formulation of FANO effectively inhibited tumor growth with minimal side-effects, providing a potent combined nitric oxide therapy for malignancy.

Deuterium Isotope Effects in Condensed-Phase Thermochemical Decomposition Reactions of Octahydro-1,3,5,7-tetranitro-1,3,5,7-tetrazocine

The deuterium isotope effect was applied to condensed-phase thermodinamical reactions of HMX and HMX-d8 by using isothermal techniques.Dissimilar deuterium isotope effects revealed a mechanistic dependence of HMX upon different physical states which may singularly predominate in a specific type of thermal event.Solid-state HMX thermodinamical decomposition produces a primary deuterium isotope effect (DIE), indicating that covalent C-H bond rupture is the rate-controlling step in this phase.An apparent inverse DIE is displayed by the mixed melt phase and can be attributed to C-H bond contraction during a weakening of molecular lattice forces as the solid HMX liquefies.The liquid-state decomposition rate appears to be controlled by ring C-N bond cleavage as evidenced by a secondary DIE and higher molecular weight products.These results reveal a dependence of the HMX decomposition process on physical state and lead to a broader mechanistic interpretation which explains the seemingly contradictory data found in current literature reviews.